Atıf İçin Kopyala
Arik H. O., Yalcin A. D., Celik B., Seyman D., Tetik G., Gursoy B., ...Daha Fazla
MEDICAL SCIENCE MONITOR, cilt.20, ss.1078-1081, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
20
-
Basım Tarihi:
2014
-
Dergi Adı:
MEDICAL SCIENCE MONITOR
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1078-1081
-
Anahtar Kelimeler:
Biological Markers - analysis, Biological Markers - chemistry, Diabetic Foot - blood, Diabetic Nephropathies - blood, Diabetic Nephropathies - diagnosis, Diabetic Nephropathies - immunology, 25-HYDROXYVITAMIN D, MANAGEMENT, SCD200, OMALIZUMAB, IL-1-BETA, SEVERITY, STRAIL
-
Dokuz Eylül Üniversitesi Adresli:
Hayır
Özet
Background: CD200 (OX-2) is a novel immune-effective molecule, existing in a cell membrane-bound form, as well as in a soluble form in serum (s OX-2), which acts to regulate inflammatory and acquired immune responses.